On Wednesday, Aileron Therapeutics Inc (NASDAQ; ALRN) revealed topline data from Cohort 2 of its Phase 1b trial of safety and ...

High-dose LTI-03 (5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both pathological basal-like cells and fibroblasts and decreased the expression of a ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

These cells include alveolar type 2 (AT2 ... model will enable studying the basic causes of diseases like pulmonary fibrosis, as well as the testing of potential new drugs, according to the ...

South Korean researchers have developed a new technology that can recognize and detect lung diseases such as Chronic ...

Pulmonary fibrosis, including its most common form ... epithelial cells initiate and perpetuate the disease, including alveolar type 2 (AT2) cells, which are responsible for maintaining the ...

Pulmonary fibrosis, including its most common form ... epithelial cells initiate and perpetuate the disease, including alveolar type 2 (AT2) cells, which are responsible for maintaining the ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third ...

6). There was marked interalveolar fibrosis, and the alveolar walls blended with the interstitial fibrous tissue. Giant-cell reaction to the concretions was present, most of the giant cells being ...

Electronics and Telecommunications Research Institute (ETRI) stated that they have successfully developed a new technology ...